Global Medical REIT Stock Forecast, Price & News

Global Medical REIT (NYSE:GMRE) Frequently Asked Questions

Is Global Medical REIT a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Global Medical REIT stock.
View analyst ratings for Global Medical REIT or view top-rated stocks.

How has Global Medical REIT's stock been impacted by COVID-19?

Global Medical REIT's stock was trading at $12.41 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, GMRE shares have increased by 38.2% and is now trading at $17.15.
View which stocks have been most impacted by COVID-19.

Are investors shorting Global Medical REIT?

Global Medical REIT saw a drop in short interest during the month of December. As of December 31st, there was short interest totaling 809,700 shares, a drop of 25.0% from the December 15th total of 1,080,000 shares. Based on an average trading volume of 386,100 shares, the short-interest ratio is presently 2.1 days. Currently, 1.3% of the shares of the company are short sold.
View Global Medical REIT's Short Interest.

When is Global Medical REIT's next earnings date?

Global Medical REIT is scheduled to release its next quarterly earnings announcement on Wednesday, March 2nd 2022.
View our earnings forecast for Global Medical REIT.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc. (NYSE:GMRE) posted its quarterly earnings data on Wednesday, November, 3rd. The company reported $0.06 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.23 by $0.17. Global Medical REIT had a trailing twelve-month return on equity of 2.94% and a net margin of 13.46%. During the same period last year, the firm posted $0.23 EPS.
View Global Medical REIT's earnings history.

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT announced a quarterly dividend on Tuesday, December 14th. Investors of record on Monday, December 27th will be paid a dividend of $0.205 per share on Monday, January 10th. This represents a $0.82 dividend on an annualized basis and a yield of 4.78%. The ex-dividend date of this dividend is Thursday, December 23rd.
View Global Medical REIT's dividend history.

Is Global Medical REIT a good dividend stock?

Global Medical REIT pays an annual dividend of $0.82 per share and currently has a dividend yield of 4.78%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Global Medical REIT has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Global Medical REIT is 546.70%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Global Medical REIT will have a dividend payout ratio of 84.54% in the coming year. This indicates that Global Medical REIT may not be able to sustain their current dividend.
View Global Medical REIT's dividend history.

What price target have analysts set for GMRE?

4 brokerages have issued 1 year target prices for Global Medical REIT's shares. Their forecasts range from $16.00 to $18.00. On average, they expect Global Medical REIT's stock price to reach $17.25 in the next year. This suggests a possible upside of 0.6% from the stock's current price.
View analysts' price targets for Global Medical REIT or view top-rated stocks among Wall Street analysts.

Who are Global Medical REIT's key executives?

Global Medical REIT's management team includes the following people:

• Jeffrey Mark Busch, Chairman, President & Chief Executive Officer
• Danica Holley, Chief Operating Officer
• Robert J. Kiernan, Chief Financial Officer & Treasurer
• Alfonzo Leon, Chief Investment Officer
• Allen E. Webb, Senior VP-SEC Reporting & Technical Accounting

Who are some of Global Medical REIT's key competitors?

Some companies that are related to Global Medical REIT include Physicians Realty Trust (DOC), DigitalBridge Group (DBRG), Lexington Realty Trust (LXP), Broadstone Net Lease (BNL), Apple Hospitality REIT (APLE), Safestore (SFSHF), PotlatchDeltic (PCH), Macerich (MAC), JBG SMITH Properties (JBGS), Phillips Edison & Company Inc (PECO), Outfront Media (OUT), Hannon Armstrong Sustainable Infrastructure Capital (HASI), EPR Properties (EPR), Chimera Investment (CIM) and SITE Centers (SITC).
View all of GMRE's competitors.

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include (PFG), INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Square (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

When did Global Medical REIT IPO?

(GMRE) raised $130 million in an IPO on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

What is Global Medical REIT's stock symbol?

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Sound Income Strategies LLC (0.46%) and Wedbush Securities Inc. (0.24%). Company insiders that own Global Medical REIT stock include Henry Cole, Jeffrey Busch and Ronald Marston.
View institutional ownership trends for Global Medical REIT.

Which institutional investors are buying Global Medical REIT stock?

GMRE stock was acquired by a variety of institutional investors in the last quarter, including Sound Income Strategies LLC, and Wedbush Securities Inc.. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Jeffrey Busch, and Ronald Marston.
View insider buying and selling activity for Global Medical REIT or or view top insider-buying stocks.

How do I buy shares of Global Medical REIT?

Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Medical REIT's stock price today?

One share of GMRE stock can currently be purchased for approximately $17.15.

How much money does Global Medical REIT make?

Global Medical REIT has a market capitalization of $1.10 billion and generates $93.73 million in revenue each year. The company earns $-1.92 million in net income (profit) each year or $0.15 on an earnings per share basis.

How many employees does Global Medical REIT have?

Global Medical REIT employs 22 workers across the globe.

What is Global Medical REIT's official website?

The official website for Global Medical REIT is www.globalmedicalreit.com.

Where are Global Medical REIT's headquarters?

Global Medical REIT is headquartered at 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814.

How can I contact Global Medical REIT?

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at (202) 524-6851 or via email at [email protected].